Literature DB >> 22812187

Decrease of the regulatory T-cell population by adoptive T-cell transfer in a mouse colorectal cancer transplant model.

Tsuguhiro Matsumoto1, Satoshi Kokura, Takeshi Ishikawa, Jun Funaki, Satoko Adachi, Koji Mori, Naoyuki Sakamoto, Kazuhiro Katada, Kazuhiro Kamada, Nobuaki Yagi, Osamu Handa, Tomohisa Takagi, Kazuhiko Uchiyama, Yuji Naito, Toshikazu Yosikawa.   

Abstract

We examined the effects of adoptive T-cell transfer (ACT) on the population of regulatory T cells (Tregs) in a mouse colorectal cancer transplant model. In an in vivo study, Treg populations in Balb/c mice colon26 transplant model after ACT were analyzed in peripheral blood, local lymph node, and tumor. In an in vitro study CD4+ cells were cultured in medium containing TGF-beta to induce Tregs. LAK cells were added or not in this Treg induction system. Treg induction after coculture with LAK was investigated. We also studied the role of IFN-gamma in the mechanism of Treg induction. Tregs in the draining lymph nodes and tumor were significantly suppressed by ACT. The induction of Tregs in vitro was inhibited by coculture with LAK cells. Furthermore, Tregs in the cultured cells were significantly inhibited by addition of exogenous IFN-gamma. Moreover, Tregs were increased by addition of IFN-gamma mAb. ACT may decrease Tregs in tumor-bearing hosts. One of the mechanisms is considered to be IFN-gamma inhibiting the induction of Tregs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22812187     DOI: 10.3727/096504012x13340632812596

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  1 in total

1.  Phase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer.

Authors:  Takeshi Ishikawa; Satoshi Kokura; Tatsuji Enoki; Naoyuki Sakamoto; Tetsuya Okayama; Mitsuko Ideno; Junichi Mineno; Kazuko Uno; Naohisa Yoshida; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Osamu Handa; Tomohisa Takagi; Hideyuki Konishi; Nobuaki Yagi; Yuji Naito; Yoshito Itoh; Toshikazu Yoshikawa
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.